Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

New England Journal of Medicine · 2002 · 19K citations · Full text

Medicine, Endocrinology, Diabetology +1

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Jaakko Tuomilehto, Jaana Lindström, Johan G. Eriksson et al. · New England Journal of Medicine · 2001 · 10.9K citations · Full text

Medicine, Endocrinology, Preventive Medicine +12

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis et al. · The Lancet · 2002 · 2.5K citations

Medicine, Pharmacotherapy, Preventive Medicine +14